Obbligazioni societarie HIGH YIELD e oltre, verso frontiere inesplorate - Vol. 2

J.C. Penney Takes On $400 Million In 2nd-Lien Debt

J.C. Penney is adding $400 million in 8.625% second-lien notes due 2025.
It is using the proceeds mainly for its tender offer for its 2019 and 2020 unsecured notes.
The 2019 and 2020 notes are now essentially dealt with, but I believe the ultimate goal of these moves is to improve J.C. Penney's 2023 secured debt situation.
J.C. Penney will incur around $50 million to $60 million in costs in order to ultimate reduce its 2023 first-lien debt principal by around $340 to $350 million.
I view these moves as being slightly negative for J.C. Penney's stock and slightly positive for its longer-term unsecured debt.
 
*** XINYUAN US$ 2YR - UPDATE #1 ***


** NEW USD 2YR ANNOUNCED (03/2020)

** IPG: 9.875% AREA

** SIZE: USD 200MM (CAPPED)

** TIMING: AS EARLY AS TODAY'S BUSINESS
 
Valeant Pharmaceuticals Intl : Announces Launch Of Private Offering Of Senior Notes | 4-Traders

Valeant Pharmaceuticals Intl : And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,250,000,000 Outstanding Principal Amount | 4-Traders

Valeant launches $1.25B private debt offering

Valeant Pharmaceuticals (NYSE:VRX) commences a private offering of $1.25B aggregate principal amount of unsecured senior notes due 2026.

Net proceeds will help fund the repurchase of $1.25B of outstanding debt, including its 6.375% Senior Notes due 2020, 5.375% Senior Notes due 2020 and up to $100M of its 6.750% Senior Notes due 2021.
 
Vuol dire che io tuo portafoglio titoli vale molto. :d: Scherzi a parte è un problema ricorrente di questi tempi. Occorre trovare singole occasioni. Oggi ad esempio ho visto un bel segno meno su Mattel 2025.
 

Users who are viewing this thread

Back
Alto